Stockreport

ADC Therapeutics SA (ADCT) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic ... [Yahoo! Finance]

ADC Therapeutics SA Common Shares  (ADCT) 
PDF This article first appeared on GuruFocus Q4 2025 Net Product Revenue: $22.3 million, up from $16.4 million in Q4 2024. Full-Year 2025 Net Product Revenue: $73.6 mil [Read more]